Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination therapy containing zosuquidar reverses multidrug resistance in AML

March 25, 2003

Long-lasting antitumor activity reported for Bexxar in refractory B-cell lymphoma

March 25, 2003

Photofrin approved in Canada for HGD associated with Barrett's esophagus

March 24, 2003

CV Therapeutics identifies adenosine A3 receptor agonists with utility in cancer and neutropenia

March 24, 2003

Promising preclinical findings for aplidine in leukemia and lymphoma

March 21, 2003

OncoMab and Medarex join forces for cancer antibody development

March 21, 2003

Shionogi BioResearch claims compounds with Taxol-enhancing activity

March 21, 2003

DTI-015 affords 40% cure rate and over 400% increase in life span in rats with brain cancer

March 20, 2003

Pharmagenesis and Pierre Fabre sign license agreement for PG-490-88Na

March 20, 2003

New antiangiogenic peptides with utility in cancer claimed by Abbott

March 20, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...